title: IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma.
abstract: Recently, a link between high levels of circulating IL-6 and hepatocellular carcinoma (HCC) has been proposed. In addition, single nucleotide polymorphisms (SNPs) in the promoter region of the IL-6 gene have been reported to be related to several inflammatory-related conditions, including cancer. The purpose of this article is: (1) to evaluate the frequencies of SNPs in the IL-6 promoter region at position -174 and IL-6 serum levels in a group of patients with HCC and underlying liver cirrhosis (LC), and compare them with a group of LC patients without HCC; (2) to determine whether a possible correlation exists between the allelic variations, IL-6 serum levels, and the risk of developing HCC. The study included 105 HCC and 95 LC patients. Genomic DNA was isolated using commercially available kits. DNA samples were typed for relevant SNPs of the IL-6 promoter region (-174 G>C, G allele being associated with higher levels of the cytokine). The Restriction Fragment Length Polymorphism (RFLP-PCR) method was used to type the SNPs. IL-6 serum levels were determined using an ultrasensitive commercially available ELISA kit. IL-6 serum levels were higher in G/G compared to C/C genotypes only in HCC (z=2; p=0.04) and G/G versus G/C (z=1.8; p<0.03). IL-6 serum levels in G carriers (G/G+G/C) were higher in HCC 4.8 (0.2-17.5) versus LC patients 2.2 (0.07-11.5) (z=2.8; p=0.004). There was no difference for genotype C/C. IL-6 serum levels in HCC correlated with G carriers (G/G+G/C) (ρ=0.25, p=0.05). A positive correlation was also found between sIL-6 levels and some parameters of liver function both in LC and in HCC patients.
authors.affiliation: Department of Clinical Medicine and Emerging Pathologies, University of Palermo, and Department of Human Pathology, ARNAS Civico Hospital, Palermo, Italy. lydiagiannitp@gmail.com
authors.forename: Lydia
authors.initials: L
authors.lastname: Giannitrapani
authors.forename: Maurizio
authors.initials: M
authors.lastname: Soresi
authors.forename: Antonio
authors.initials: A
authors.lastname: Giacalone
authors.forename: Maria Elisa
authors.initials: ME
authors.lastname: Campagna
authors.forename: Marta
authors.initials: M
authors.lastname: Marasà
authors.forename: Melchiorre
authors.initials: M
authors.lastname: Cervello
authors.forename: Salvatore
authors.initials: S
authors.lastname: Marasà
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Montalto
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000097:blood* / Q000235:genetics*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D015850:Interleukin-6 / Q000097:blood* / Q000235:genetics*; D008103:Liver Cirrhosis / Q000097:blood* / Q000235:genetics; D008113:Liver Neoplasms / Q000097:blood* / Q000235:genetics; D008297:Male; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*
chemical_list: D015850:Interleukin-6